• Register
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.


Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.


P63 alpha mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome.

p63, a p53 family member, is required for craniofacial and limb development as well as proper skin differentiation. However, p63 mutations associated with the ankyloblepharon-ectodermal dysplasia-clefting (AEC) syndrome (Hay-Wells syndrome) were found in the p63 carboxyl-terminal region with a sterile alpha-motif. By two-hybrid screen we identified several proteins that interact with the p63alpha carboxyl terminus and its sterile alpha-motif, including the apobec-1-binding protein-1 (ABBP1). AEC-associated mutations completely abolished the physical interaction between ABBP1 and p63alpha. Moreover the physical association of p63alpha and ABBP1 led to a specific shift of FGFR-2 alternative splicing toward the K-SAM isoform essential for epithelial differentiation. We thus propose that a p63alpha-ABBP1 complex differentially regulates FGFR-2 expression by supporting alternative splicing of the K-SAM isoform of FGFR-2. The inability of mutated p63alpha to support this splicing likely leads to the inhibition of epithelial differentiation and, in turn, accounts for the AEC phenotype.

Pubmed ID: 12692135


  • Fomenkov A
  • Huang YP
  • Topaloglu O
  • Brechman A
  • Osada M
  • Fomenkova T
  • Yuriditsky E
  • Trink B
  • Sidransky D
  • Ratovitski E


The Journal of biological chemistry

Publication Data

June 27, 2003

Associated Grants

  • Agency: NIAID NIH HHS, Id: R01-AI47224
  • Agency: NIDCR NIH HHS, Id: R01-DE13561

Mesh Terms

  • Abnormalities, Multiple
  • Animals
  • Cell Differentiation
  • DNA-Binding Proteins
  • Ectodermal Dysplasia
  • Epithelial Cells
  • Gene Expression Regulation
  • Genes, Tumor Suppressor
  • Heterogeneous-Nuclear Ribonucleoprotein Group A-B
  • Humans
  • Membrane Proteins
  • Mice
  • Mouth Abnormalities
  • Mutation
  • Phosphoproteins
  • Protein Binding
  • Protein Isoforms
  • Protein Splicing
  • RNA-Binding Proteins
  • Receptor, Fibroblast Growth Factor, Type 2
  • Receptors, Fibroblast Growth Factor
  • Syndrome
  • Trans-Activators
  • Transcription Factors
  • Tumor Suppressor Proteins
  • Two-Hybrid System Techniques